secwatch.observer — SEC 8-K summary
======================================

Issuer:     Accelerate Diagnostics, Inc (—)
CIK:        0000727207
Form:       8-K
Filed at:   2023-07-10T23:59:59+00:00
Accession:  0001104659-23-079367
Event type: other
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AXDX receives Nasdaq delisting notice; will implement 1-for-10 reverse stock split to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq delisting determination on July 6, 2023 for failure to meet $1.00 minimum bid price; appeal filed to stay suspension.
- Board approved 1-for-10 reverse stock split effective July 11, 2023 at 5:00 PM ET; trading on split-adjusted basis July 12, 2023.
- Outstanding shares will reduce from ~144M to ~14M; fractional shares paid in cash.
- No change to authorized shares or par value; proportionate adjustments to equity awards, warrants, and convertible notes.
- If appeal fails or compliance not regained, common stock subject to delisting from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727207/000110465923079367/0001104659-23-079367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727207/000110465923079367/tm2320924d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-079367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer